Personal Information
Organização/Local de trabalho
San Francisco, California United States
Cargo
Entrepreneur, Biotech, Drug Discovery and Development, University Teaching Experience
Setor
Medical / Health Care / Pharmaceuticals
Site
http://alquest.us/
Sobre
• 15+ years in biotech and pharma profession: Research and Development team leader
• Preclinical PK and bioanalytical study administrator: designed preclinical DMPK and bioanalytical protocols implemented by CROs that allowed for “go/no go” decisions within budget
• Early discovery, preclinical and clinical team experience: worked on early discovery and preclinical project teams as well as on programs involving Phase 1 and Phase 2 clinical candidates
• Managed DMPK programs running concurrently in several therapeutic areas: cardiovascular, gastrointestinal, antiviral, and neurological disorders
• Entrepreneurial spirit: identified new potential therapeutic opportunities for...
Marcadores
cyp2c9
cyp3a4
cyp450s
adducts
mechanism-based inactivation
mass spectrometry
Ver mais
Apresentações
(11)Personal Information
Organização/Local de trabalho
San Francisco, California United States
Cargo
Entrepreneur, Biotech, Drug Discovery and Development, University Teaching Experience
Setor
Medical / Health Care / Pharmaceuticals
Site
http://alquest.us/
Sobre
• 15+ years in biotech and pharma profession: Research and Development team leader
• Preclinical PK and bioanalytical study administrator: designed preclinical DMPK and bioanalytical protocols implemented by CROs that allowed for “go/no go” decisions within budget
• Early discovery, preclinical and clinical team experience: worked on early discovery and preclinical project teams as well as on programs involving Phase 1 and Phase 2 clinical candidates
• Managed DMPK programs running concurrently in several therapeutic areas: cardiovascular, gastrointestinal, antiviral, and neurological disorders
• Entrepreneurial spirit: identified new potential therapeutic opportunities for...
Marcadores
cyp2c9
cyp3a4
cyp450s
adducts
mechanism-based inactivation
mass spectrometry
Ver mais